Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
ESMO Congress 2026 · Barcelona, Spain
31 shown of 2,373 total abstracts
  1. Abstract 92432026-09-02 · 15:30 CT · E450
    Real-world effectiveness of Keytruda vs standard of care in SCLC
    A. Spira, S. Antonia, P. Schmid, et al. · Institut Gustave Roussy
    Clinical Science SymposiumLung Cancer—Small Cell📄🖼️
  2. Abstract 95352026-09-01 · 16:45 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-233
    J. Cortes, N. Rizvi, S. Tolaney, et al. · Peter MacCallum Cancer Centre
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  3. Abstract 95592026-09-01 · 19:00 CT · Hall B1
    Real-world effectiveness of Enhertu vs standard of care in NSCLC
    H. Borghaei, M.C. Garassino · Peter MacCallum Cancer Centre
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  4. Abstract 90252026-09-05 · 20:30 CT · S406
    Quality of life outcomes with Keytruda in patients with SCLC
    S. Peters, A. Spira, H. Rugo, et al. · Dana-Farber Cancer Institute
    Clinical Science SymposiumLung Cancer—Small Cell📄🖼️
  5. Abstract 95512026-09-04 · 15:00 CT · E450
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-435 study)
    J. Cortes, M. Krop, A. Spira · Cleveland Clinic
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  6. Abstract 90522026-09-01 · 13:15 CT · S406
    FLAURA-78: Tagrisso (osimertinib) neoadjuvant in NSCLC
    C. Robert, T. Mok, J. Cortes, et al. · Dana-Farber Cancer Institute
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  7. Abstract 95512026-09-04 · 14:00 CT · S100A
    Long-term follow-up of Imfinzi maintenance for NSCLC: PACIFIC-485
    C. Saura, C. Robert, N. Rizvi, et al. · Princess Margaret Cancer Centre
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  8. Abstract 95332026-09-02 · 19:15 CT · S406
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-239
    M. Reck, C. Robert, M. Krop · Chinese University of Hong Kong
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  9. Abstract 90892026-09-04 · 21:45 CT · E450
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-173 study)
    S. Tolaney, T. Mok, M.C. Garassino, et al. · Memorial Sloan Kettering Cancer Center
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  10. Abstract 90822026-09-03 · 18:00 CT · Arie Crown Theater
    Quality of life outcomes with Tagrisso in patients with NSCLC
    A. Spira, M. Krop, H. Rugo · National Cancer Center Japan
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  11. Abstract 98522026-09-03 · 14:15 CT · Arie Crown Theater
    Real-world effectiveness of Opdivo vs standard of care in NSCLC
    C. Saura, C. Robert, S. Antonia, et al. · Princess Margaret Cancer Centre
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  12. Abstract 91092026-09-03 · 16:30 CT · Hall B1
    PACIFIC-745: Imfinzi (durvalumab) 1L in NSCLC
    J. Cortes, S. Antonia, S. Tolaney, et al. · Johns Hopkins Kimmel Cancer Center
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  13. Abstract 99912026-09-03 · 15:15 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-478
    J. Cortes, S. Peters · Stanford Cancer Institute
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  14. Abstract 95222026-09-03 · 13:00 CT · S100A
    Long-term follow-up of Imfinzi maintenance for NSCLC: PACIFIC-832
    J. Cortes, H. Borghaei, H. Rugo, et al. · Karolinska Institute
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  15. Abstract 97472026-09-04 · 15:30 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-386 study)
    H. Borghaei, N. Rizvi, L. Paz-Ares, et al. · Institut Gustave Roussy
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  16. Abstract 95412026-09-05 · 16:30 CT · Hall B1
    Long-term follow-up of Tecentriq adjuvant for NSCLC: IMpower-533
    A. Spira, C. Saura, S. Tolaney, et al. · Dana-Farber Cancer Institute
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  17. Abstract 91832026-09-02 · 16:15 CT · S100A
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-493
    H. Rugo, N. Rizvi, P. Schmid, et al. · Institut Gustave Roussy
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  18. Abstract 91292026-09-01 · 18:45 CT · Arie Crown Theater
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-927 study)
    N. Rizvi, S. Modi, H. Rugo, et al. · University of Chicago
    Clinical Science SymposiumLung Cancer—Small Cell📄🖼️
  19. Abstract 91382026-09-01 · 18:45 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-411 study)
    N. Rizvi, S. Peters · Institut Gustave Roussy
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  20. Abstract 97682026-09-02 · 16:45 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso adjuvant for NSCLC: FLAURA-505
    M.C. Garassino, P. Schmid, S. Tolaney · MD Anderson Cancer Center
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  21. Abstract 92352026-09-03 · 18:00 CT · Hall B1
    Quality of life outcomes with Imfinzi in patients with NSCLC
    P. Schmid, J. Cortes, S. Tolaney, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  22. Abstract 92332026-09-05 · 15:45 CT · S100A
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-765
    S. Antonia, J. Brahmer, N. Rizvi, et al. · University of Chicago
    Clinical Science SymposiumLung Cancer—Small Cell📄🖼️
  23. Abstract 91892026-09-03 · 20:30 CT · E450
    Real-world effectiveness of Keytruda vs standard of care in NSCLC
    E. Winer, M. Krop, P. Schmid, et al. · Vall d'Hebron Institute of Oncology
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  24. Abstract 93142026-09-04 · 20:15 CT · Arie Crown Theater
    Real-world effectiveness of Tecentriq vs standard of care in NSCLC
    M.C. Garassino, T. Mok, A. Spira · UCSF Helen Diller Family Comprehensive Cancer Center
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  25. Abstract 97012026-09-04 · 14:15 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso adjuvant for NSCLC: FLAURA-879
    A. Spira, N. Rizvi, E. Winer, et al. · Vall d'Hebron Institute of Oncology
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  26. Abstract 92542026-09-02 · 13:15 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-983
    M.C. Garassino, T. Mok · National Cancer Center Japan
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  27. Abstract 99152026-09-05 · 13:15 CT · Hall B1
    Long-term follow-up of Imfinzi 2L for SCLC: PACIFIC-781
    E. Winer, N. Rizvi · Princess Margaret Cancer Centre
    Clinical Science SymposiumLung Cancer—Small Cell📄🖼️
  28. Abstract 91352026-09-03 · 15:45 CT · S100A
    CheckMate-446: Opdivo (nivolumab) neoadjuvant in NSCLC
    N. Rizvi, H. Borghaei, A. Spira · Princess Margaret Cancer Centre
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  29. Abstract 90332026-09-04 · 13:15 CT · Arie Crown Theater
    Long-term follow-up of Keytruda 1L for NSCLC: KEYNOTE-244
    S. Modi, J. Cortes, N. Rizvi, et al. · Chinese University of Hong Kong
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  30. Abstract 91402026-09-01 · 14:45 CT · E450
    Long-term follow-up of Tecentriq 1L for NSCLC: IMpower-866
    S. Modi, A. Spira, C. Robert, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  31. Abstract 96612026-09-01 · 20:30 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-756 study)
    S. Modi, M. Krop, L. Paz-Ares, et al. · National Cancer Center Japan
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.